SK
Sampat Kumar
About Sampat Kumar
Data last updated:
Sampat Kumar is a Director at Cllovemed Pharma Private Limited (since 2023). The company operates in Pharma. Cllovemed Pharma Private Limited reported revenue of ₹27.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cllovemed Pharma Private Limited U74999HP2018PTC007007 | Director | 27 Feb 2023 | 2018 | ₹27.1 Lakh (FY 2024) | Active |
Board colleagues of Sampat Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shubham Singh | 10047740 | Cllovemed Pharma Private Limited | Director |
| Suman Pathania | 10055054 | Cllovemed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sampat Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sampat Kumar
Sampat Kumar currently holds 1 directorship: Cllovemed Pharma Private Limited (Director, since 27 Feb 2023, revenue ₹27.1 Lakh (FY 2024)).
Sampat Kumar was first appointed on 27 Feb 2023 as Director at Cllovemed Pharma Private Limited.
The current boards of Sampat Kumar's companies include Shubham Singh (Cllovemed Pharma Private Limited), Suman Pathania (Cllovemed Pharma Private Limited).